Synergetic effects of HGF and antibacterial treatment

Details Synergetic effects of HGF and antibacterial treatment Synergetic effects of HGF and antibacterial treatment

2001-08-28

2009-10-13

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

Reexamination Certificate

active

07601365

ABSTRACT:
Methods of treating a skin ulcer of a mammal comprise providing an antibiotic or fungicide, and HGF to said mammal. Additional methods of treating a mammal with a skin ulcer comprise identifying a mammal with a skin ulcer as one in need of an antibiotic and HGF, and providing an antibiotic and HGF to the identified mammal.

REFERENCES:
patent: 5004805 (1991-04-01), Gohda et al.
patent: 5342831 (1994-08-01), Nakamura et al.
patent: 5648273 (1997-07-01), Bottaro et al.
patent: 5656443 (1997-08-01), Goldberg et al.
patent: 5776464 (1998-07-01), Nakamura
patent: 5827673 (1998-10-01), Matsumori
patent: 5840311 (1998-11-01), Nakamura et al.
patent: 5855918 (1999-01-01), Mrsny et al.
patent: 5977310 (1999-11-01), Namiki et al.
patent: 6036972 (2000-03-01), Nakamura et al.
patent: 6303126 (2001-10-01), Nakamura et al.
patent: 6756358 (2004-06-01), Iwamoto et al.
patent: 2003/0176347 (2003-09-01), Nakamura et al.
patent: 462549 (1991-12-01), None
patent: 722737 (1996-07-01), None
patent: 724884 (1996-08-01), None
patent: 784980 (1997-07-01), None
patent: 847757 (1998-06-01), None
patent: 890361 (1999-01-01), None
patent: 1074264 (2001-02-01), None
patent: 8268907 (1996-10-01), None
patent: 93 06853 (1993-04-01), None
patent: 94 04175 (1994-03-01), None
patent: 80 35968 (1996-02-01), None
patent: 96 05855 (1996-02-01), None
patent: WO 96/41818 (1996-12-01), None
patent: 98 24467 (1998-06-01), None
patent: 98 41227 (1998-09-01), None
patent: 99 55361 (1999-11-01), None
patent: WO 01/44294 (2001-06-01), None
patent: 02 22162 (2002-03-01), None
NPUAP Report—Jul. 29, 2000.
Hepatocyte Growth Factor (HGF) in Patients with Pneumonia: A Comparison Between Survivors and Non-Survivors; Nayeri, et al, 1998 Scandinavian University Press. ISSN 0036-5548; Scand J. Infec Dis 30; 405-409, 1998.
Shiota et al, “Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells”,Proc. Natl. Acad. Sci., vol. 89, pp. 373-377, Jan. 1992.
Brzozowski et al, “Involvement of Cycclooxygenase (Cox)-2 Products in Acceleration of Ulcer Healing by Gastrin and Hepatocyte Growth Factor”,Journal of Physiology and Pharmacology, 2000, 51, 4, pp. 751-773.
Morishita et al, “Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy”,Hypertension, Jun. 1999, pp. 1379-1384.
Takahashi et al, “Hepatocyte Growth Factor as a Key to Modulate Anti-Ulcer Action of Prostaglandins in Stomach”,J. Clin. Invest., vol. 98, No. 11, Dec. 1996, pp. 2604-2611.
Tashiro et al, “Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues”,Proc. Natl. Acad. Sci., vol. 87, pp. 3200-3204, Apr. 1990.
Taipale et al, “Hepatocyte Growth Factor Releases Epithelial and Endothelial Cells from Growth Arrest Induced by Transforming Growth Factor-β1”,The Journal of Biological Chemistry, vol. 271, No. 8, Feb. 23, 1996, pp. 4342-4348.
Nayeri et al, “Hepatocyte Growth Factor Levels in Cerebrospinal Fluid: A Comparison Between Acute Bacterial and Nonbacterial Meningitis”,The Journal of Infectious Diseases, 2000; 181, pp. 2092-2094.
Gohda et al, “Purification and Partial Characterization of Hepatocyte Growth Factor from Plasma of a Patient with Fulminant Hepatic Failure”,J. Clin. Invest., vol. 81, Feb. 1988, pp. 414-419.
Takahashi et al, “Hepatocyte Growth Factor Is the Most Potent Endogenous Stimulant of Rabbit Gastric Epithelial Cell Proliferation and Migration in Primary Culture”,J. Clin. Invest., vol. 95, May 1995, pp. 1994-2003.
Huang et al, “Serum Hepatocyte Growth Factor Levels in Patients With Inflammatory Lung Diseases,” Kaohsiung J. Med. Sci. 15:195-201, 1999.
Ueda et al, “Hepatocyte Growth Factor in Assessment of Acute Pancreatitis: Comparison With C-Reactive Protein and Interleukin-6,” J. Gastroenterol, 1997; 32:63-70.
Matsuno et al, “Clinical Evaluation of Hepatocyte Growth Factor in Patients With Gastrointestinal and Pancreatic Diseases With Special Reference to Inflammatory Bowel Disease,” Research Communications in Molecular Pathology and Pharmacology, vol. 97, No. 1, Jul. 1997, pp. 25-37.
Tsubouchi et al, “Levels of the Human Hepatocyte Growth Factor in Serum of Patients With Various Liver Diseases Determined by an Enzyme-Linked Immunosorbent Assay,” Hepatology, vol. 13, No. 1, 1991, pp. 1-5.
Database Medline, U.S. National Library of Medicine (NLM), Bethesda, MD, US; Jul. 1998, Prokhorova M. N. et al: “[The use of noninvasive biological means in assessing lipids in children]”, Database Accession No. NLM9742758, Klinicheskaia Laboratornaia Diagnostika, Jul. 1998, No. 7, Jul. 1998, pp. 13-15.

Affiliated with

Also associated with

Rating

Synergetic effects of HGF and antibacterial treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergetic effects of HGF and antibacterial treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergetic effects of HGF and antibacterial treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4109226